Diabetes management: optimizing roles for nurses in insulin initiation

References

• KirtlandKALiYFGeissLSThompsonTJState-specific incidence of diabetes among adults–participating states, 1995–1997 and 2005–2007MMWR Morb Mortal Wkly Rep200857431169117318971918
   PubMedGoogle Scholar
• BurdenMDiabetes: treatment and complications–the nurse’s roleNurs Times20039923032
   Google Scholar
• UK Prospective Diabetes Study GroupIntensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)Lancet199835291318378539742976
   PubMed Web of Science ®Google Scholar
• StrattonIMAdlerAINeilHAAssociation of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational studyBMJ2000321725840541210938048
   PubMed Web of Science ®Google Scholar
• Diabetes Control and Complications Trial Research GroupEffect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the Diabetes Control and Complications Trial. A randomized, controlled trialAnn Intern Med199812875175239518395
   PubMed Web of Science ®Google Scholar
• SteffesMWSibleySJacksonMThomasWBeta-cell function and the development of diabetes-related complications in the Diabetes Control and Complications TrialDiabetes Care200326383283612610045
   PubMed Web of Science ®Google Scholar
• DCCT/EDIC Research GroupIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetesN Engl J Med2005353252643265316371630
   PubMed Web of Science ®Google Scholar
• SelvinECoreshJGoldenSHBolandLLBrancatiFLSteffesMWGlycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes: the Atherosclerosis Risk in Communities studyDiabetes Care20052881965197316043740
   PubMed Web of Science ®Google Scholar
• HolmanRRPaulSKBethelMAMatthewsDRNeilHA10-year follow-up of intensive glucose control in type 2 diabetesN Engl J Med2008359151577158918784090
   PubMed Web of Science ®Google Scholar
• GaedePVedelPParvingH-HPedersenOIntensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised studyLancet1999353915361762210030326
   PubMed Web of Science ®Google Scholar
• Advance Collaborative GroupIntensive blood glucose control and vascular outcomes in patients with type 2 diabetesN Engl J Med2008358242560257218539916
   PubMed Web of Science ®Google Scholar
• LiYXuWLiaoZInduction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell functionDiabetes Care200427112597260215504992
   PubMed Web of Science ®Google Scholar
• WengJLiYXuWEffect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trialLancet200837196261753176018502299
   PubMed Web of Science ®Google Scholar
• NathanDMBuseJBDavidsonMBMedical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement of the American Diabetes Association and the European Association for the Study of DiabetesDiabetes Care200932119320318945920
   PubMed Web of Science ®Google Scholar
• American Association of Clinical EndocrinologistsAmerican Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitusEndocr Pract200713Suppl 1468
   Google Scholar
• ACE/AACE Diabetes Road Map Task ForceRoad map for the prevention and treatment of type 2 diabetesEndocr Pract200612Suppl 1148151
   Google Scholar
• IDF Clinical Guidelines Task ForceGlobal guideline for type 2 diabetesBrusselsInternational Diabetes Federation2005179
   Google Scholar
• MannucciEMonamiMLamannaCGoriFMarchionniNPrevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trialsNutr Metab Cardiovasc Dis200919960461219427768
   PubMed Web of Science ®Google Scholar
• American Diabetes AssociationStandards of medical care in diabetes–2010Diabetes Care201033Suppl 1S11S6120042772
   PubMed Web of Science ®Google Scholar
• American Association of Clinical EndocrinologistsState of diabetes in America http://www.aace.com/public/awareness/stateofdiabetes/DiabetesAmericaReport.pdf. Accessed Nov 18 2010.
   Google Scholar
• TibaldiJRakelREWhy, when and how to initiate insulin therapy in patients with type 2 diabetesInt J Clin Pract200761463364417394436
   PubMed Web of Science ®Google Scholar
• TurnerRCCullCAFrighiVHolmanRRGlycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49)JAMA1999281212005201210359389
   PubMed Web of Science ®Google Scholar
• HirschIBInsulin analoguesN Engl J Med2005352217418315647580
   PubMed Web of Science ®Google Scholar
• GallwitzBSitagliptin: profile of a novel DPP-4 inhibitor for the treatment of type 2 diabetesDrugs Today (Barc)2007431132517315049
   PubMed Web of Science ®Google Scholar
• LebovitzHETherapeutic options in development for management of diabetes: pharmacologic agents and new technologiesEndocr Pract200612Suppl 114214716627399
   PubMedGoogle Scholar
• Diabetes Forecast2008 Resource guide – insulinDiabetes Forecast2008611RG11RG1418290288
   PubMedGoogle Scholar
• KorytkowskiMNiskanenLAsakuraTFlexPen®: addressing issues of confidence and convenience in insulin deliveryClin Ther200527Suppl BS89S10016519040
   PubMed Web of Science ®Google Scholar
• LeeWCBaluSCobdenDJoshiAVPashosCLMedication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims dataClin Ther200628101712172517157128
   PubMed Web of Science ®Google Scholar
• RiddleMCMaking the transition from oral to insulin therapyAm J Med2005118Suppl 5A14S20S15850549
   PubMed Web of Science ®Google Scholar
• BoylePJZrebiecJPhysiological and behavioral aspects of glycemic control and hypoglycemia in diabetesSouth Med J2007100217518217330688
   PubMed Web of Science ®Google Scholar
• RollaARRakelREPractical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analoguesClin Ther20052781113112516199240
   PubMed Web of Science ®Google Scholar
• LevyPInsulin analogs or premixed insulin analogs in combination with oral agents for treatment of type 2 diabetesMed Gen Med20079212
   PubMedGoogle Scholar
• FunnellMMKrugerDFSpencerMSelf-management support for insulin therapy in type 2 diabetesDiabetes Educ200430227428015095517
   PubMed Web of Science ®Google Scholar
• SiminerioLMFunnellMMPeyrotMRubinRRUS nurses’ perceptions of their role in diabetes care: results of the cross-national Diabetes Attitudes Wishes and Needs (DAWN) StudyDiabetes Educ200733115216217272801
   PubMed Web of Science ®Google Scholar
• WoerleHJNeumannCZschauSImpact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes importance of postprandial glycemia to achieve target HbA1c levelsDiabetes Res Clin Pract200777228028517240473
   PubMed Web of Science ®Google Scholar
• RiddleMCRosenstockJGerichJThe treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patientsDiabetes Care200326113080308614578243
   PubMed Web of Science ®Google Scholar
• Novo NordiskLevemir insulin dosing options for diabetes treatment http://www.novomedlink.com/products/Levemir/about-dosing.aspx. Accessed Nov 18 2010.
   Google Scholar
• American Diabetes AssociationStandards of medical care in diabetes–2009Diabetes Care200932Suppl 1S13S6119118286
   PubMed Web of Science ®Google Scholar
• TibaldiJImportance of postprandial glucose levels as a target for glycemic control in type 2 diabetesSouth Med J20091021606619077774
   PubMed Web of Science ®Google Scholar
• MonnierLLapinskiHColetteCContributions of fasting and post-prandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c)Diabetes Care200326388188512610053
   PubMed Web of Science ®Google Scholar
• Diabetes Control and Complications Trial Research GroupHypoglycemia in the Diabetes Control and Complications TrialDiabetes19974622712869000705
   PubMed Web of Science ®Google Scholar
• Diabetes Control and Complications Trial Research GroupInfluence of intensive diabetes treatment on body weight and composition of adults with type 1 diabetes in the Diabetes Control and Complications TrialDiabetes Care200124101711172111574431
   PubMed Web of Science ®Google Scholar
• RossettiPPorcellatiFFanelliCGPerrielloGTorloneEBolliGBSuperiority of insulin analogues versus human insulin in the treatment of diabetes mellitusArch Physiol Biochem2008114131018465353
   PubMedGoogle Scholar
• BoylePJZrebiecJManagement of diabetes-related hypoglycemiaSouth Med J2007100218319417330689
   PubMed Web of Science ®Google Scholar
• BruntonSANocturnal hypoglycemia: answering the challenge with long-acting insulin analogsMed Gen Med20079238
   Google Scholar
• SinghSRAhmadFLalAYuCBaiZBennettHEfficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysisCMAJ2009180438539719221352
   PubMed Web of Science ®Google Scholar
• GerichJEInsulin glargine: long-acting basal insulin analog for improved metabolic controlCurr Med Res Opin2004201313714741069
   PubMed Web of Science ®Google Scholar
• HermansenKDaviesMDerezinskiTRavnGMClausonPHomePA 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetesDiabetes Care20062961269127416732007
   PubMed Web of Science ®Google Scholar
• RaslovaKTamerSCClausonPKarlDInsulin detemir results in less weight gain than NPH insulin when used in basal-bolus therapy for type 2 diabetes mellitus, and this advantage increases with baseline body mass indexClin Drug Invest2007274279285
   PubMed Web of Science ®Google Scholar
• RaskinPGylvinTWengWChaykinLComparison of insulin detemir and insulin glargine using a basal-bolus regimen in a randomized, controlled clinical study in patients with type 2 diabetesDiabetes Metab Res Rev200925654254819565569
   PubMed Web of Science ®Google Scholar
• HartmanIInsulin analogs: impact on treatment success, satisfaction, quality of life, and adherenceClin Med Res200862546718801953
   PubMedGoogle Scholar
• RobbinsDCBeisswengerPJCerielloAMealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparisonClin Ther200729112349236418158076
   PubMed Web of Science ®Google Scholar
• IlagLLKerrLMaloneJKTanMHPrandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparisonClin Ther2007296P12541270
   Web of Science ®Google Scholar
• BruntonSInsulin delivery systems: reducing barriers to insulin therapy and advancing diabetes mellitus treatmentAm J Med2008121Suppl 6S35S4118514089
   PubMed Web of Science ®Google Scholar
• DavisEMBebeeACrawfordLDestacheCNurse satisfaction using insulin pens in hospitalized patientsDiabetes Educ200935579980919633151
   PubMed Web of Science ®Google Scholar
• DaviesMLavalle-GonzalezFStormsFGomisRInitiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trialDiabetes Obes Metab200810Suppl 2424918577156
   PubMed Web of Science ®Google Scholar
• SelamJLKoenenCWengWMeneghiniLImproving glycemic control with insulin detemir using the 303 algorithm in insulin naive patients with type 2 diabetes: a subgroup analysis of the US PREDICTIVE 303 studyCurr Med Res Opin2008241112018021495
   PubMed Web of Science ®Google Scholar
• GreavesCJBrownPTerryRTEiserCLingsPSteadJWConverting to insulin in primary care: an exploration of the needs of practice nursesJ Adv Nurs200342548749612752869
   PubMed Web of Science ®Google Scholar
• DaviesMSinnassamyPStormsFGomisRInsulin glargine-based therapy improves glycemic control in patients with type 2 diabetes sub-optimally controlled on premixed insulin therapiesDiabetes Res Clin Pract200879236837517980928
   PubMed Web of Science ®Google Scholar
• BlondeLMerilainenMKarweVRaskinPPatient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets – the TITRATE studyDiabetes Obes Metab200911662363119515182
   PubMed Web of Science ®Google Scholar
• StrangePTreat-to-target insulin titration algorithms when initiating long or intermediate acting insulin in type 2 diabetesJ Diabetes Sci Technol20071454054819885117
   PubMedGoogle Scholar
• WattsSAGeeJO’DayMENurse practitioner-led multidisciplinary teams to improve chronic illness care: the unique strengths of nurse practitioners applied to shared medical appointments/group visitsJ Am Acad Nurse Pract200921316717219302693
   PubMed Web of Science ®Google Scholar
• RollnickSMillerWWhat is motivational interviewing?Behav Cogn Psychother199523325334
   Google Scholar
• ResnicowKDiIorioCSoetJEErnstDBorrelliBHechtJMotivational interviewing in health promotion: it sounds like something is changingHealth Psychol200221544445112211511
   PubMed Web of Science ®Google Scholar
• ClarkMHampsonSEImplementing a psychological intervention to improve lifestyle self-management in patients with type 2 diabetesPatient Educ Couns200142324725611164324
   PubMed Web of Science ®Google Scholar
• RollnickSMillerWButlerCCMotivational Interviewing in Health Care: Helping Patients Change BehaviorNew York, NYGuilford Press2008
   Google Scholar
• GarberAJWahlenJWahlTAttainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study)Diabetes Obes Metab200681586616367883
   PubMed Web of Science ®Google Scholar
• GabrielyIShamoonHHypoglycemia in diabetes: common, often unrecognizedCleve Clin J Med200471433534215117175
   PubMed Web of Science ®Google Scholar
• MeeceJDispelling myths and removing barriers about insulin in type 2 diabetesDiabetes Educ200632Suppl 19S18S16439485
   PubMed Web of Science ®Google Scholar
• Arendt-NielsenLEgekvistHBjerringPPain following controlled cutaneous insertion of needles with different diametersSomatosens Mot Res2006231–2374316846958
   PubMed Web of Science ®Google Scholar
• ScainSFFriedmanRGrossJLA structured educational program improves metabolic control in patients with type 2 diabetes: a randomized controlled trialDiabetes Educ200935460361119451553
   PubMed Web of Science ®Google Scholar
• WagnerEHChronic disease management: what will it take to improve care for chronic illness?Eff Clin Pract1998112410345255
   PubMedGoogle Scholar